Medication info

Gastor Injection 20 Milligrams (Famotidine)

Prescription medicationInjectionsOral · Intravenous injection
Ingredient · strength
Famotidine›20mg / 1mL
Manufacturer / importer
Dong-A ST Co., Ltd.
Appearance
A colorless to pale yellow transparent liquid in a colorless and transparent vial.
Packaging
10 vials/box [10 milliliters/vial × 10]
Approval status
Active

MFDS item code 202203264 · Approved 2022.08.11 · Insurance code 642507651

Summary

Main use
Suppression of upper gastrointestinal bleeding, preanesthetic medication, and treatment of Zollinger-Ellison syndrome
Who uses it
Adults
Adult dosage
Suppression of upper gastrointestinal bleeding due to peptic ulcer, acute stress ulcer, or hemorrhagic gastritis; Zollinger-Ellison syndrome; and upper gastrointestinal bleeding due to physical stress (after major surgery, severe cerebrovascular disordersㆍ head traumaㆍ multiple organ failureㆍ severe burns): In adults, dilute this drug (20mg/10mL injection) with 10mL of normal saline injection or glucose injection to prepare a 20mg/20mL solution per dose. Administer slowly by intravenous injection twice daily (every 12 hours) or mix with an infusion solution and administer by intravenous drip. - Upper gastrointestinal bleeding and Zollinger-Ellison syndrome : The effect generally appears within 1 week. Switch to oral administration once oral dosing becomes possible. - Suppression of upper gastrointestinal bleeding : Administer for approximately 3 days for physical stress after major surgery and approximately 7 days for other physical stress. When used as preanesthetic medication, in adults dilute this drug (20mg/10mL injection) with 10mL of normal saline injection or glucose injection to prepare a 20mg/20mL solution per dose, and administer slowly by intravenous injection 1 hour before induction of anesthesia. After dilution, use within 48 hours when stored at room temperature or refrigerated. Adjust the dose appropriately according to age and symptoms.

Ingredients

Manufacturer
Dong-A ST Co., Ltd.

Efficacy & effects

Suppression of upper gastrointestinal bleeding, preanesthetic medication, and treatment of Zollinger-Ellison syndrome

  • Upper gastrointestinal bleeding
  • peptic ulcers
  • acute stress ulcers
  • hemorrhagic gastritis
  • Zollinger-Ellison syndrome
  • upper gastrointestinal bleeding due to physical stress.
View approved original text

This medication is used to inhibit upper gastrointestinal bleeding, particularly from peptic ulcers, acute stress ulcers, and hemorrhagic gastritis. It also treats conditions of excessive gastric acid secretion, such as Zollinger-Ellison syndrome, and prevents upper gastrointestinal bleeding caused by physical stress from major surgeries, severe cerebrovascular disorders, head trauma, multiple organ failure, and severe burns. Lastly, it reduces gastric acid secretion prior to anesthesia, thereby lowering the risk of gastric contents regurgitating into the esophagus during surgery. It effectively acts on various upper gastrointestinal-related diseases and conditions to improve symptoms and assist in treatment.

Dosage and Administration

Adult dosage

Suppression of upper gastrointestinal bleeding due to peptic ulcer, acute stress ulcer, or hemorrhagic gastritis; Zollinger-Ellison syndrome; and upper gastrointestinal bleeding due to physical stress (after major surgery, severe cerebrovascular disordersㆍ head traumaㆍ multiple organ failureㆍ severe burns): In adults, dilute this drug (20mg/10mL injection) with 10mL of normal saline injection or glucose injection to prepare a 20mg/20mL solution per dose. Administer slowly by intravenous injection twice daily (every 12 hours) or mix with an infusion solution and administer by intravenous drip. - Upper gastrointestinal bleeding and Zollinger-Ellison syndrome : The effect generally appears within 1 week. Switch to oral administration once oral dosing becomes possible. - Suppression of upper gastrointestinal bleeding : Administer for approximately 3 days for physical stress after major surgery and approximately 7 days for other physical stress. When used as preanesthetic medication, in adults dilute this drug (20mg/10mL injection) with 10mL of normal saline injection or glucose injection to prepare a 20mg/20mL solution per dose, and administer slowly by intravenous injection 1 hour before induction of anesthesia. After dilution, use within 48 hours when stored at room temperature or refrigerated. Adjust the dose appropriately according to age and symptoms.

Precautions

This medication should not be used in patients who are hypersensitive to its components. Patients with impaired renal function should use this medication with caution, as their blood concentration may increase; therefore, the dosage may need to be reduced or the dosing interval increased. Caution is required in patients with heart disease due to the risk of cardiovascular side effects. Patients with liver dysfunction may also experience exacerbation of symptoms; hence, careful administration is necessary. Elderly patients are likely to have decreased renal function, making dose adjustments necessary due to the potential increase in drug concentration. This medication can rarely cause serious allergic reactions, blood disorders, skin conditions, liver dysfunction, muscle damage, cardiac arrhythmia, and renal impairment, so the administration should be stopped immediately if any abnormal symptoms occur, and health care professionals should be consulted. Common side effects can include dyspepsia, rash, changes in blood values, and neurological symptoms; therefore, attention should be given if symptoms arise. It is only to be used in specific situations, such as prevention of postoperative stress-induced gastrointestinal bleeding, and the treatment duration and dosage must be strictly adhered to. There may be interactions with other drugs, so if any other medications are being taken, it is essential to inform healthcare professionals. Women who are pregnant or may become pregnant should carefully consider the necessity of this medication, and breastfeeding should be discontinued during use. Safety in pediatric patients has not been sufficiently established, so this medication should be used cautiously in children. When using an ampoule, it should be cleaned to avoid contamination by glass fragments. This medication may mask the symptoms of gastric cancer, so it should be confirmed that gastric cancer is not present before administration.

Side effects

  • Shock
  • hypersensitivity
  • anaphylaxis
  • dyspnea
  • systemic rash
  • angioedema
  • urticaria
  • pancytopenia
  • agranulocytosis
  • aplastic anemia
Show 68 more
  • hemolytic anemia
  • general malaise
  • weakness
  • subcutaneous and mucosal bleeding
  • fever
  • Stevens-Johnson syndrome
  • Riel syndrome
  • liver dysfunction
  • jaundice
  • rhabdomyolysis
  • hyperkalemia
  • myoglobinuria
  • serum enzyme elevation
  • myalgia
  • QT prolongation
  • ventricular tachycardia
  • Torsades de Pointes
  • ventricular fibrillation
  • altered consciousness
  • seizures
  • generalized convulsions
  • interstitial nephritis
  • acute renal failure
  • rash
  • wheals
  • facial edema
  • leukopenia
  • thrombocytopenia
  • eosinophilia
  • constipation
  • diarrhea
  • soft stools
  • thirst
  • nausea
  • vomiting
  • abdominal distension
  • loss of appetite
  • stomatitis
  • hypertension
  • facial flushing
  • tinnitus
  • bradycardia
  • tachycardia
  • atrioventricular block
  • bronchospasm
  • AST elevation
  • ALT elevation
  • ALP elevation
  • total bilirubin elevation
  • LDH elevation
  • liver dysfunction
  • general malaise
  • lethargy
  • headache
  • drowsiness
  • insomnia
  • hallucinations
  • anxiety
  • agitation
  • decreased libido
  • sensory disturbances
  • heaviness
  • reversible confusional state
  • depression
  • irregular menstruation
  • gynecomastia
  • arthralgia
  • CK elevation

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to protect it from exposure to air, ideally at room temperature between 1 and 30 degrees Celsius. This storage method ensures that the drug's effectiveness is well maintained and prevents deterioration.

Appearance and packaging

Appearance

A colorless to pale yellow transparent liquid in a colorless and transparent vial.

Package unit

10 vials/box [10 milliliters/vial × 10]

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.